• Profile
Close

An assessment of 18F-FDG PET/CT for thoracic screening and risk stratification of pulmonary nodules in multiple endocrine neoplasia type 1

Clinical Endocrinology Apr 03, 2018

So A, et al. - In order to detect the thoracic lesions and for the prognostic assessment of thoracic lesions in multiple endocrine neoplasia type 1 (MEN 1), experts exploratively analyzed the fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) at a tertiary referral hospital between July 2011 and December 2016. It was found that 26.0% cases illustrated pulmonary nodules with multiple nodules identified in nine (18.0%) subjects. Data disclosed that all FDG-avid lesions increased in size vs 11 (42.3%) FDG nonavid lesions. The median doubling time was discovered to be 24.2 months and 48.6 months, respectively for FDG-avid and nonavid nodules. Thus, it was deduced that thoracic imaging with 18F-FDG PET/CT effectively detected the pulmonary nodules and ThC. The FDG-avid pulmonary lesions exhibited a considerably greater tendency of progressing than nonavid lesions.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay